Literature DB >> 33797290

Improvement of Opal Multiplex Immunofluorescence Workflow for Human Tissue Sections.

Marcella Willemsen1,2,3,4, Gabrielle Krebbers1,2,3,4, Marcel W Bekkenk1,2,3,4, Marcel B M Teunissen1, Rosalie M Luiten1,2,3,4.   

Abstract

The Opal multiplex technique is an established methodology for the detection of multiple biomarkers in one section. The protocol encompasses iterative single stainings and heating-mediated removal of the primary and secondary antibodies after each staining round, leaving untouched the Opal fluorophores which are deposited onto the antigen of interest. According to our experience, repetitive heating of skin sections often results in tissue damage, indicating an urgent need for milder alternatives to strip immunoglobulins. In this study, we demonstrate that considerable heating-related damage was found not only in skin but also in tissues of different origin, mostly characterized by low cell density. Importantly, the morphology remained fully intact when sections were repetitively exposed to β-mercaptoethanol-containing stripping buffer instead of multiple heating cycles. However, target epitopes appeared sensitive at a differential degree to multiple treatments with stripping buffer, as shown by loss in staining intensity, but in all cases, the staining intensity could be restored by increment of the primary antibody concentrations. Application of β-mercaptoethanol-containing stripping buffer instead of heating for antibody removal markedly improved the quality of the Opal multiplex technique, as a substantial higher number of differently colored cells could be visualized within a well-conserved morphological context.

Entities:  

Keywords:  fluorescent antibody technique; immunohistochemistry; skin

Year:  2021        PMID: 33797290     DOI: 10.1369/00221554211007793

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  5 in total

1.  Development of a Multiplex Immunohistochemistry Workflow to Investigate the Immune Microenvironment in Mouse Models of Inflammatory Bowel Disease and Colon Cancer.

Authors:  Lokman Pang; Matthias Ernst; Jennifer Huynh
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

2.  siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.

Authors:  Jae Yun Jung; Hyun Jin Ryu; Seung-Hwan Lee; Dong-Young Kim; Myung Ji Kim; Eun Ji Lee; Yeon-Mi Ryu; Sang-Yeob Kim; Kyu-Pyo Kim; Eun Young Choi; Hyung Jun Ahn; Suhwan Chang
Journal:  Cells       Date:  2021-10-13       Impact factor: 6.600

3.  Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren's syndrome.

Authors:  Naoki Kaneko; Hu Chen; Cory A Perugino; Takashi Maehara; Ryusuke Munemura; Shiho Yokomizo; Junsei Sameshima; Thomas J Diefenbach; Katherine R Premo; Akira Chinju; Yuka Miyahara; Mizuki Sakamoto; Masafumi Moriyama; John H Stone; Seiji Nakamura; Shiv Pillai
Journal:  Sci Rep       Date:  2022-09-14       Impact factor: 4.996

Review 4.  Navigating the cellular landscape in tissue: Recent advances in defining the pathogenesis of human disease.

Authors:  Helen Y Chen; Umaimainthan Palendira; Carl G Feng
Journal:  Comput Struct Biotechnol J       Date:  2022-09-15       Impact factor: 6.155

5.  ENPP1 deletion causes mouse osteoporosis via the MKK3/p38 MAPK/PCNA signaling pathway.

Authors:  Qiang Wang; Zhiqiang Gao; Kai Guo; Jiawei Lu; Feng Wang; Yufeng Huang; Desheng Wu
Journal:  J Orthop Surg Res       Date:  2022-10-15       Impact factor: 2.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.